A partnership has been formed between Alveo Technologies and the University of Texas Medical Branch to develop diagnostics. The focus of this collaboration is on creating point-of-care diagnostics for a specific disease. The disease being targeted is Lassa Fever, which is prevalent in West Africa.

Further details about this partnership and the development of these diagnostics are available from the source. In Galveston, Texas, where the University of Texas Medical Branch is located, this partnership is likely to have some local impact, although specifics are not provided. For more information, readers can refer to the original announcement from PR Newswire.